Literature DB >> 7283972

The multiple complexes formed by the interaction of platelet factor 4 with heparin.

P E Bock, M Luscombe, S E Marshall, D S Pepper, J J Holbrook.   

Abstract

The anisotropy of the fluorescence of dansyl (5-dimethylaminonaphthalene-1- sulphonyl) groups covalently attached to human platelet factor 4 was used to detect the macromolecular compounds formed when the factor was mixed with heparin. At low heparin/protein ratios a very-high-molecular-weight compound (1) was formed that dissociated to give a smaller compound (2) when excess heparin was added. 2. A large complex was also detected as a precipitate that formed at high protein concentrations in chloride buffer. It contained 15.7% (w/w) polysaccharide, equivalent to four or five heparin tetrasaccharide units per protein tetramer. In this complex, more than one molecule of protein binds to each heparin molecule of molecular weight greater than about 6 X 10(3).3. The stability of these complexes varied with pH, salt concentration and the chain length of the heparin. The limit complexes found in excess of the larger heparins consisted of only one heparin molecule per protein tetramer, and the failure to observe complexes with four heparin molecules/protein tetramer is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7283972      PMCID: PMC1162276          DOI: 10.1042/bj1910769

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Malate dehydrogenase of the cytosol. Ionizations of the enzyme-reduced-coenzyme complex and a comparison with lactate dehydrogenase.

Authors:  A Lodola; D M Parker; R Jeck; J J Holbrook
Journal:  Biochem J       Date:  1978-08-01       Impact factor: 3.857

2.  New method for quantitative determination of uronic acids.

Authors:  N Blumenkrantz; G Asboe-Hansen
Journal:  Anal Biochem       Date:  1973-08       Impact factor: 3.365

3.  Method for determination of the sulfate content of glycosaminoglycans.

Authors:  T T Terho; K Hartiala
Journal:  Anal Biochem       Date:  1971-06       Impact factor: 3.365

4.  Uronic acid composition of heparins and heparan sulfates.

Authors:  R L Taylor; J E Shively; H E Conrad; J A Cifonelli
Journal:  Biochemistry       Date:  1973-09-11       Impact factor: 3.162

5.  Platelet antiheparin activity. The isolation and characterisation of platelet factor 4 released from thrombin-aggregated washed human platelets and its dissociation into subunits and the isolation of membrane-bound antiheparin activity.

Authors:  S Moore; D S Pepper; J D Cash
Journal:  Biochim Biophys Acta       Date:  1975-02-27

6.  Purification and binding properties of human platelet factor four.

Authors:  R I Handin; H J Cohen
Journal:  J Biol Chem       Date:  1976-07-25       Impact factor: 5.157

7.  Coupling of glycosaminoglycans to agarose beads (sepharose 4B).

Authors:  P H Iverius
Journal:  Biochem J       Date:  1971-10       Impact factor: 3.857

8.  Protein-protein interactions in blood clotting. The use of polarization of fluorescence to measure the dissociation of plasma factor XIIIa.

Authors:  J M Freyssinet; B A Lewis; J J Holbrook; J D Shore
Journal:  Biochem J       Date:  1978-02-01       Impact factor: 3.857

9.  Equilibrium binding of nicotinamide nucleotides to lactate dehydrogenases.

Authors:  R A Stinson; J J Holbrook
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857

10.  Amino acid sequence of human platelet factor 4.

Authors:  T F Deuel; P S Keim; M Farmer; R L Heinrikson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

View more
  26 in total

1.  Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.

Authors:  S R Hanson; L A Harker
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.

Authors:  Laurent O Mosnier
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

3.  The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21).

Authors:  Sanjay Khandelwal; Grace M Lee; C Garren Hester; Mortimer Poncz; Steven E McKenzie; Bruce S Sachais; Lubica Rauova; Garnett Kelsoe; Douglas B Cines; Michael Frank; Gowthami M Arepally
Journal:  Blood       Date:  2016-07-13       Impact factor: 22.113

4.  Platelet Factor 4 Interactions with Short Heparin Oligomers: Implications for Folding and Assembly.

Authors:  Chendi Niu; Yang Yang; Angela Huynh; Ishac Nazy; Igor A Kaltashov
Journal:  Biophys J       Date:  2020-04-21       Impact factor: 4.033

5.  Modulation of heparin cofactor II activity by histidine-rich glycoprotein and platelet factor 4.

Authors:  D M Tollefsen; C A Pestka
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Effect of heparin and a low-molecular weight heparinoid on PAF-induced airway responses in neonatally immunized rabbits.

Authors:  M Sasaki; C M Herd; C P Page
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Comparative studies of the interaction of human and bovine platelet factor 4 with heparin using histidine NMR resonances as spectroscopic probes.

Authors:  C J Talpas; L Lee
Journal:  J Protein Chem       Date:  1993-06

8.  Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.

Authors:  D A Lane; J Denton; A M Flynn; L Thunberg; U Lindahl
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

Review 9.  Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.

Authors:  Douglas B Cines; Keith R McCrae; X Long Zheng; Bruce S Sachais; Eline T Luning Prak; Don L Siegel
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

10.  Heparin binding to platelet factor-4. An NMR and site-directed mutagenesis study: arginine residues are crucial for binding.

Authors:  K H Mayo; E Ilyina; V Roongta; M Dundas; J Joseph; C K Lai; T Maione; T J Daly
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.